IMMUNOGLOBULIN WITH TANDEM ARRANGEMENT OF FAB FRAGMENTS AND APPLICATION THEREOF Russian patent published in 2022 - IPC C07K16/46 A61K39/395 

Abstract RU 2769133 C2

FIELD: biochemistry.

SUBSTANCE: group of inventions relates to multivalent and multispecific binding proteins and an application thereof. Binding protein contains three polypeptide chains: the first polypeptide chain contains, from the amino terminus to the carboxy terminus, (i) VLA-CL-VHB-CH1-Fc, where CL is fused directly to VHB, or (ii) VHB-CH1-VLA-CL-Fc, where CH1 is fused directly to VLA, and wherein there are no inserted linkers between the variable domains and constant domains; the second polypeptide chain contains, from the amino terminus to the carboxy terminus, VHA-CH1, wherein there are no inserted linkers between VHA and CH1; the third polypeptide chain contains, from the amino terminus to the carboxy terminus, VLB-CL, wherein there are no inserted linkers between VLB and CL. Two of said first polypeptide chains, two of said second polypeptide chains, and two of said third polypeptide chains are therein capable of associating forming a tetravalent binding protein with double specificity containing six polypeptide chains containing four Fab functional binding fragments. Said binding protein binds both epitope or antigen A and epitope or antigen B. A and B therein constitute different epitopes of the same antigen or different antigens.

EFFECT: binding proteins can be used for treating or preventing acute and chronic inflammatory diseases and disorders, autoimmune diseases, malignant tumours, and other diseases and disorders; proposed structure provides sufficient flexibility and corresponding dimensional parameters for double binding in the absence of a peptide spacer between 2 Fab-binding regions.

32 cl, 7 dwg, 16 tbl, 4 ex

Similar patents RU2769133C2

Title Year Author Number
HIGH-AFFINITY ANTI-PD-1 AND ANTI-LAG-3 ANTIBODIES AND BISPECIFIC BINDING PROTEINS OBTAINED FROM THEM 2019
  • Wu, Xuan
  • Gong, Shiyong
  • Wu, Chengbin
RU2782381C2
IMMUNOGLOBULIN WITH TANDEM FAB- FRAGMENTS AND ITS APPLICATION OPTIONS 2017
  • U, Chenbin
RU2767329C2
PROTEIN BINDING WITH NKG2D, CD16 AND WITH TUMOR-SPECIFIC ANTIGEN 2018
  • Chang, Gregory P.
  • Cheung, Ann F.
  • Haney, William
  • Lunde, Bradley M.
  • Prinz, Bianka
RU2788531C2
CRYOPRESERVED CELLS ARE NATURAL KILLERS PRELOADED WITH ANTIBODY CONSTRUCTION 2019
  • Rojsh, Uve
  • Kokh, Joakhim
  • Treder, Martin
  • Dulat, Kholger J.
RU2819927C2
MULTIVALENT PD-L1-BINDING COMPOUNDS FOR TREATING MALIGNANT NEOPLASMS 2020
  • Barry, Michael, A.
RU2816646C2
PROTEINS BINDING NKG2D, CD16 AND TUMOUR-ASSOCIATED ANTIGEN 2018
  • Chang, Gregory, P.
  • Cheung, Ann, F.
  • Haney, William
  • Lunde, Bradley, M.
  • Prinz, Bianka
  • Grinberg, Asya
RU2816716C2
TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS USING CROSSOVER FORMAT WITH DOUBLE VARIABLE DOMAIN (CODV) FOR TREATING INFECTION CAUSED BY HIV 2020
  • Asokan, Mangaiarkarasi
  • Beil, Christian
  • Beninga, Jochen
  • Birkenfeld, Joerg
  • Connors, Mark
  • Koup, Richard A.
  • Kwon, Young Do
  • Kwong, Peter D.
  • Liu, Qingbo
  • Lusso, Paolo
  • Mascola, John R.
  • Nabel, Gary J.
  • Pegu, Amarendra
  • Rao, Ercole
  • Wei, Ronnie
  • Xu, Ling
  • Yang, Zhi-Yong
RU2820164C2
TRISPECIFIC BINDING PROTEINS, RELATED METHODS AND VERSIONS OF USE THEREOF 2020
  • Birkenfeld, Joerg
  • Nabel, Gary J.
  • Qiu, Huawei
  • Regula, Joerg
  • Seung, Edward
  • Wei, Ronnie
  • Wu, Lan
  • Xing, Zhen
  • Xu, Ling
  • Prades, Catherine
  • Dabdoubi, Tarik
  • Cameron, Beatrice
  • Lemoine, Cendrine
  • Yang, Zhi-Yong
RU2822200C2
INDUCIABLE BINDING PROTEINS AND THEIR USE 2017
  • Baeuerle, Patrick
  • Dubridge, Robert, B.
  • Wesche, Holger
  • Evnin, Luke
  • Guenot, Jeanmarie
  • Panchal, Anand
  • Vinogradova, Maia
RU2800034C2
FUNCTION PROTEIN AND ITS USE 2019
  • Lv, Ming
  • Ding, Xiaoran
  • Miao, Shiwei
  • Tan, Bin
  • Wang, Xuegong
RU2800923C2

RU 2 769 133 C2

Authors

Wu, Chengbin

Dates

2022-03-28Published

2014-12-24Filed